PolarityTE to Participate in Corporate Access Event in San Francisco, January 8 – 9, 2018

SALT LAKE CITY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. COOL today announced that its senior management team will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place in San Francisco, January 8-9, 2018.

To schedule a meeting with PolarityTE, investors can register on the online system managed by the Company's US investor relations firm, LifeSci Advisors, LLC, or make a request via e-mail at Access@LifeSciAdvisors.com.

About PolarityTE

PolarityTE, Inc. is a regenerative medicine company, and the first to successfully regenerate full-thickness tissue. The Company's novel regenerative medicine platform and proprietary technology employs a patient's own cells for the healing of full-thickness, functionally-polarized tissues. If clinically successful, the PolarityTE™ platform will provide medical professionals with a truly new paradigm in wound healing and reconstructive surgery by utilizing a patient's own tissue substrates for the potential regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The PolarityTE™ platform leverages natural and biologically-sound principles which are readily adaptable to a wide spectrum of organ and tissue systems. This revolutionary technology, paired with the Company's world-renowned clinical advisory board, position PolarityTE™ to drastically change the field and future of translational regenerative medicine. More information can be found online at www.PolarityTE.com.

CONTACT

John Stetson

InvestorRelations@PolarityTE.com 

(385) 237-2365

Investors:

Hans Vitzthum

LifeSci Advisors, LLC

617-535-7743

Hans@LifeSciAdvisors.com